Gene Biotherapeutics, Inc.

Gene Biotherapeutics, Inc.

CRXM
Gene Biotherapeutics, Inc.US flagOther OTC
0.00
USD
+0.00
- -
6,493.00Market Cap

Income Statement (USD)

APIChatGPT
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
As of date
12/31/2006
12/31/2007
12/31/2008
12/31/2009
12/31/2010
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
Sales/Revenue/Turnover
1
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
1
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
19
26
18
9
7
7
8
7
4
3
3
2
1
1
1
+ Selling, General & Admin
10
12
7
5
5
5
6
5
3
3
2
2
1
1
1
+ Research & Development
8
13
11
4
2
3
3
2
1
- -
1
- -
- -
- -
- -
+ Other Operating Expense
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-19
-26
-17
-9
-7
-7
-8
-7
-4
-3
-3
-2
-1
-1
-1
- Non-Operating (Income) Loss
-19
-26
-17
-9
-7
- -
- -
- -
2
1
- -
- -
-1
-2
-1
+ Interest Expense, Net
- -
- -
- -
6
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
1
6
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-19
-26
-18
-15
-7
- -
- -
- -
2
- -
- -
- -
-1
-2
-1
Pretax Income
- -
- -
- -
- -
- -
-7
-8
-7
-6
-4
-3
-2
-1
1
-1
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-19
-25
-18
-16
-5
-7
-8
-7
-6
-4
-3
-2
-1
1
-1
- Net Extraordinary Losses (Gains)
- -
- -
7
-4
- -
- -
- -
2
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
-7
4
- -
- -
- -
-2
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
14
-9
- -
- -
- -
4
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-19
-25
-25
-12
-5
-7
-8
-9
-6
-4
-3
-2
- -
1
- -
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-19
-25
-25
-12
-5
-7
-8
-9
-6
-4
-3
-2
- -
1
-1
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-19
-25
-25
-12
-5
-7
-8
-9
-6
-4
-4
-2
- -
1
-1
EBIT
-19
-26
-17
-9
-7
-7
-8
-7
-4
-3
-3
-2
-1
-1
-1
EBITDA
-18
-25
-16
-8
-7
-7
-8
-7
-4
-3
-3
-2
-1
-1
-1
EBITDA Margin (%)
-2,431.82
-1,552.59
-3,775.03
-1,751.33
-2,699.93
- -
-13,488.33
-6,052.93
- -
- -
- -
- -
- -
- -
- -
EBITA
-19
-26
-17
-9
-7
-7
-8
-7
-4
-3
-3
-2
-1
-1
-1
Gross Margin (%)
-26.19
15.01
100
100
100
- -
8.85
36.67
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-2,553.66
-1,626.45
-4,114.62
-1,958.2
-2,769.06
- -
-13,960.55
-6,324.4
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-2,458.97
-1,596.06
-5,900.06
-2,625.14
-1,937.3
- -
-14,010.18
-8,163.27
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
2
2
2
2
4
4
6
7
11
13
13
14
14
14
- -
Basic EPS, GAAP
-11.88
-12.88
-10.94
-4.77
-1.28
-1.68
-1.41
-1.33
-0.5
-0.34
-0.28
-0.13
-0.03
0.06
- -
Basic EPS from Cont Ops
-11.88
-12.88
-7.83
-6.6
-1.28
-1.68
-1.39
-0.99
-0.5
-0.29
-0.23
-0.15
-0.04
0.05
- -
Diluted Weighted Avg Shares
2
2
2
2
4
4
6
7
11
13
13
14
14
14
- -
Diluted EPS, GAAP
-11.88
-12.88
-10.94
-4.77
-1.28
-1.68
-1.41
-1.33
-0.5
-0.34
-0.28
-0.13
-0.03
0.06
- -
Diluted EPS from Cont Ops
-11.88
-12.88
-7.83
-6.6
-1.28
-1.68
-1.39
-0.99
-0.5
-0.29
-0.23
-0.15
-0.04
0.05
- -

Balance Sheet (USD)

APIChatGPT
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
As of date
12/31/2006
12/31/2007
12/31/2008
12/31/2009
12/31/2010
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
Total Current Assets
8
10
9
4
8
5
4
- -
- -
- -
1
- -
- -
- -
- -
+ Cash, Cash Equivalents & STI
6
8
8
3
7
5
2
- -
- -
- -
1
- -
- -
- -
- -
+ Cash & Cash Equivalents
6
8
1
3
7
5
2
- -
- -
- -
1
- -
- -
- -
- -
+ ST Investments
- -
- -
7
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
1
1
2
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
1
-1
1
1
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
6
7
1
1
2
2
4
2
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
1
2
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
1
2
1
1
1
1
1
1
1
1
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
1
1
1
1
1
1
1
1
1
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
2
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
2
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
6
5
1
1
1
2
3
1
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
6
5
4
- -
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
6
5
4
- -
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
1
-3
1
- -
- -
2
1
- -
- -
- -
- -
- -
- -
- -
Total Assets
14
17
10
5
10
8
8
3
1
- -
1
- -
- -
- -
1
+ Payables & Accruals
3
4
5
3
1
1
- -
1
2
3
3
4
5
4
4
+ Accounts Payable
1
1
3
2
1
1
- -
1
1
2
2
2
2
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
2
1
- -
1
- -
- -
- -
1
1
2
2
3
3
3
+ ST Debt
- -
1
4
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
+ ST Borrowings
- -
1
4
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
2
5
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
2
5
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
3
5
11
7
2
1
1
2
2
4
4
5
6
5
5
+ LT Debt
- -
3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
3
8
11
8
2
1
1
2
2
4
4
5
6
5
5
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
35
58
73
74
88
94
103
107
109
110
114
114
114
114
116
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
35
58
73
74
88
94
103
107
109
110
114
114
114
114
116
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-24
-49
-74
-76
-81
-88
-96
-105
-111
-115
-117
-119
-120
-119
-119
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
11
8
-1
-2
7
6
6
1
-2
-4
-3
-5
-5
-4
-4
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
Total Equity
11
8
-1
-2
7
6
6
1
-2
-4
-3
-5
-6
-5
-5
Total Liabilities & Equity
14
17
10
5
10
8
8
3
1
- -
1
- -
- -
- -
1
Shares Outstanding
2
2
2
3
4
5
6
9
13
13
14
14
14
14
40
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
-6
-3
3
-3
-7
-5
-2
- -
- -
1
- -
1
1
1
1
Net Debt to Equity
-53.18
-35.58
-388.72
156.12
-89.44
-77.59
-36.57
-1.9
12.89
-24.37
-3.65
-22.93
-17.48
-23.11
-15.86
Tangible Common Equity Ratio
65.38
30.12
-74.86
-39.35
75.55
77.01
78.17
42.53
-225.43
-10,171.67
-296.15
-2,457.97
-3,476.88
-13,686.36
-805.74
Current Ratio
2.6
1.87
0.83
0.55
4.12
4.13
3.08
0.31
0.17
0.01
0.21
0.01
0.02
0.01
0.08
Cash Conversion Cycle
114.37
60.56
- -
- -
- -
- -
3,151.66
2,808.53
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
As of date
12/31/2006
12/31/2007
12/31/2008
12/31/2009
12/31/2010
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
+ Net Income
-19
-25
-25
-12
-5
-7
-8
-9
-6
-4
-3
-2
-1
1
-1
+ Depreciation & Amortization
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
3
2
3
1
-2
- -
- -
1
3
1
1
- -
-1
-2
-1
+ Stock-Based Compensation
- -
- -
2
1
- -
- -
- -
- -
1
1
1
- -
- -
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
1
2
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
3
2
1
- -
-2
- -
- -
- -
- -
- -
- -
- -
-1
-2
-1
+ Chg in Non-Cash Work Cap
- -
- -
3
-2
-1
-1
-1
2
- -
1
- -
1
1
1
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
-1
- -
-1
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
1
- -
3
-2
-1
- -
- -
1
- -
1
- -
1
1
1
- -
+ Inc (Dec) in Other
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-15
-21
-17
-12
-7
-8
-9
-6
-3
-1
-2
-1
- -
- -
-1
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-1
-2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
-1
-1
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
20
11
10
11
5
6
- -
- -
1
- -
- -
- -
- -
- -
+ Increase in Capital Stock
- -
20
11
10
11
5
6
- -
- -
1
- -
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-1
-2
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
1
-7
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
5
4
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
-5
-11
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
4
- -
11
- -
1
- -
4
2
- -
3
- -
- -
- -
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
1
24
12
14
11
6
7
4
3
1
3
- -
- -
- -
2
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-16
2
-7
2
3
-2
-2
-2
- -
- -
1
-1
- -
- -
- -
EBITDA
-18
-25
-16
-8
-7
-7
-8
-7
-4
-3
-3
-2
-1
-1
-1
EBITDA Margin (%)
-2,431.82
-1,552.59
-3,775.03
-1,751.33
-2,699.93
- -
-13,488.33
-6,052.93
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-16
-23
-18
-12
-7
-8
-9
-6
-3
-1
-2
-1
- -
- -
-1
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
-16
-23
-17
-18
-7
-8
-9
-6
-2
-1
-3
-1
-1
- -
-1
Free Cash Flow per Basic Share
-10.48
-11.49
-8.14
-4.74
-2.02
-1.81
-1.56
-0.86
-0.24
-0.08
-0.16
-0.07
-0.03
-0.01
- -
Price/Free Cash Flow
-7.9
-5.08
-2.26
-2.87
-3.94
-3.23
-2.45
-0.97
-0.75
-4.03
-1.1
-1.35
-1.64
-19.54
- -
Cash Flow to Net Income
0.8
0.84
0.68
0.99
1.57
1.08
1.11
0.68
0.48
0.28
0.69
0.56
1.04
-0.16
2.19
Capital Expenditures
-1
-1
-2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -